Cargando…
Genomic alterations in KMT2 family predict outcome of immune checkpoint therapy in multiple cancers
Immune checkpoint therapy (ICT) can produce durable antitumor responses in various cancer types; however, the responses are not universal, and the predictive biomarkers are urgently needed. Growing evidence points to a link between epigenetic regulation and anti-tumor immunity, while clinical data o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927217/ https://www.ncbi.nlm.nih.gov/pubmed/33653367 http://dx.doi.org/10.1186/s13045-021-01050-0 |